e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Tuberculosis: from basic science to patient care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Serum microRNA markers of tuberculoma decoy.
V. Evstifeev (Moscow, Russian Federation), G. Shepelkova (Moscow, Russian Federation), A. Ergeshova (Moscow, Russian Federation), A. Guskov (Moscow, Russian Federation), M. Bagirov (Moscow, Russian Federation), V. Yeremeev (Moscow, Russian Federation)
Source:
International Congress 2019 – Tuberculosis: from basic science to patient care
Session:
Tuberculosis: from basic science to patient care
Session type:
Thematic Poster
Number:
4596
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Evstifeev (Moscow, Russian Federation), G. Shepelkova (Moscow, Russian Federation), A. Ergeshova (Moscow, Russian Federation), A. Guskov (Moscow, Russian Federation), M. Bagirov (Moscow, Russian Federation), V. Yeremeev (Moscow, Russian Federation). Serum microRNA markers of tuberculoma decoy.. 4596
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Serum markers of acute sarcoidosis.
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020
Elevated circulating concentrations of adiponectin in sarcoidosis – a new marker of disease?
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006
Serum kinetics of total leptin and soluble leptin receptor as prognostic tools in sepsis.
Source: International Congress 2019 – Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure
Year: 2019
Serum C-reactive protein concentrations in patients with sarcoidosis: can be taken this simple test as an activation marker in sarcoidosis?
Source: Eur Respir J 2004; 24: Suppl. 48, 712s
Year: 2004
Serum microRNA signatures identified in a genome-wide profiling predict the mortality of patients with sepsis
Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections
Year: 2011
The evaluation of serum biomarkers in patients with sarcoidosis: Can visfatin be a new biomarker for sarcoidosis?
Source: International Congress 2017 – Rare diseases
Year: 2017
Serum markers of IPF
Source: Research Seminar 2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases
Year: 2004
Identification of miR-21 as a regulator of mesothelin expression using microRNA capture affinity coupled with next generation sequencing
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
Serum amyloid A as a potential biomarker of sarcoidosis
Source: Annual Congress 2011 - Lung development and neoplasia
Year: 2011
Circulating total leptin as a diagnostic and prognostic biomarker in sepsis
Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Year: 2019
Gene expression profiles of idiopathic interstitial pneumonias: Identification of disease-specific diagnostic markers and molecular therapeutic targets
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
Characterization of miRNAs circulating in sepsis patients‘ serum
Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care
Year: 2011
A set of microRNA markers of active tuberculosis.
Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis
Year: 2020
Plasma circulating miRNAs as diagnostic and prognostic biomarkers in alpha-1 antitrypsin deficiency.
Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases
Year: 2019
Levels of IGFBP-1, MMP-9 and circulating nucleosomes: a new model to diagnose SSc-ILD
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Chemokine mRNA expression profiling in pulmonary sarcoidosis
Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis
Year: 2008
The clinical significance of serum osteoprotegerin (OPG) and pro-gastrin-releasing peptide (ProGRP) concentrations in lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 318s
Year: 2004
The Pleural and blood gene expression level of GBP5 and STAT1 were associated with pleural tuberculosis: TB pleura diagnostic biomarkers.
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019
Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis
Source: Eur Respir J 2009; 34: 1376-1382
Year: 2009
Development of a new sensitive ELISA for the determination in serum of uteroglobin-related protein 1 (UGRP-1), a new potential lung biomarker
Source: Annual Congress 2010 - Innovations in the assessment of airway diseases
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept